Provided by Tiger Fintech (Singapore) Pte. Ltd.

Agree

76.27
+0.26000.34%
Volume:399.79K
Turnover:30.47M
Market Cap:8.16B
PE:42.85
High:76.58
Open:76.24
Low:75.72
Close:76.01
Loading ...

Agree Realty Corp: Strong Financial Performance and Strategic Investments Justify Buy Rating

TIPRANKS
·
12 Feb

JMP Securities Sticks to Its Hold Rating for Agree Realty (ADC)

TIPRANKS
·
12 Feb

Analysts’ Opinions Are Mixed on These Real Estate Stocks: Agree Realty (ADC) and National Retail Properties (NNN)

TIPRANKS
·
12 Feb

Strategic Positioning and Operational Execution: Analyzing Agree Realty’s Stable Growth and Disciplined Capital Allocation

TIPRANKS
·
12 Feb

Agree Realty (ADC) Q4 Earnings: How Key Metrics Compare to Wall Street Estimates

Zacks
·
12 Feb

Agree Realty Corp reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
12 Feb

Agree Realty (ADC) Surpasses Q4 FFO and Revenue Estimates

Zacks
·
12 Feb

Agree Realty Q4 Adjusted FFO, Revenue Increase

MT Newswires Live
·
12 Feb

Agree Realty: Q4 Earnings Snapshot

Associated Press Finance
·
12 Feb

Agree Realty sees FY25 AFFO $4.26-$4.30, consensus $4.30

TIPRANKS
·
12 Feb

Agree Realty Q4 2024 FFO $1.04 Beats $1.02 Estimate, Sales $160.734M Beat $156.368M Estimate

Benzinga
·
12 Feb

BRIEF-Agree Realty Q4 EPS USD 0.41 Vs. IBES Estimate USD 0.43

Reuters
·
12 Feb

Agree Realty Q4 Core Ffo per Share USD 1.02

THOMSON REUTERS
·
12 Feb

Agree Realty Corporation Reports Fourth Quarter and Full Year 2024 Results

PR Newswire
·
12 Feb

CRISPR Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2024 Financial Results

GlobeNewswire
·
12 Feb

Pfizer and Astellas’ PADCEV® (enfortumab vedotin-ejfv) plus KEYTRUDA® (pembrolizumab) Shows Long-Term Efficacy in First-Line Treatment of Locally Advanced or Metastatic Urothelial Cancer (la/mUC)

Business Wire
·
11 Feb